Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 analogue and cognitive decline in type 2 diabetes
ChiCTR-ONRC-13003095Phase 4Recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Mar 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM) and confusion (4 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoints: glucose, blood lipid and 4 more. Started Mar 2013; status: recruiting.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)confusion
Beyond the preview
Go deeper on ChiCTR-ONRC-13003095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003095.